Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Seliger

Showing results (71-80 of 304) with videos related to

Pageof 31
Sort By:
Cancer Research|December 17, 2008
Altered detoxification status and increased resistance to oxidative stress by K-ras transformationChristian V Recktenwald, Roland Kellner, Rudolf Lichtenfels, et al.
Trends in Molecular Medicine|November 7, 2008
The complex role of B7 molecules in tumor immunologyBarbara Seliger, Francesco M Marincola, Soldano Ferrone, et al.
Journal of Translational Medicine|December 24, 2015
Different maturation cocktails provide dendritic cells with different chemoattractive propertiesChiara Massa, Carolin Thomas, Ena Wang, et al.
Cancers|October 17, 2020
High PD-L1/CD274 Expression of Monocytes and Blood Dendritic Cells Is a Risk Factor in Lung Cancer Patients Undergoing Treatment with PD1 Inhibitor TherapyDagmar Riemann, Wolfgang Schütte, Steffi Turzer, et al.
Trends in Molecular Medicine|March 23, 2010
Antitumour and immune-adjuvant activities of protein-tyrosine kinase inhibitorsBarbara Seliger, Chiara Massa, Brian Rini, et al.
Journal of Translational Medicine|November 24, 2022
Characterization of the effect of histone deacetylation inhibitors on CD8<sup>+</sup> T cells in the context of agingGeorgiana Toma, Eliza Karapetian, Chiara Massa, et al.
International Journal of Cancer|March 3, 2004
Low frequency of HLA haplotype loss associated with loss of heterozygocity in chromosome region 6p21 in clear renal cell carcinomasIsabel Maleno, Miguel Angel Lopez Nevot, Barbara Seliger, et al.
Frontiers in Immunology|April 2, 2021
Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic AvenuesKarthikeyan Subbarayan, Kamatchi Ulagappan, Claudia Wickenhauser, et al.
Cancers|October 14, 2023
Blood Immune Cells as Biomarkers in Long-Term Surviving Patients with Advanced Non-Small-Cell Lung Cancer Undergoing a Combined Immune/ChemotherapyMiriam Möller, Wolfgang Schütte, Steffi Turzer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 9, 2019
Blood Immune Cell Biomarkers in Patient With Lung Cancer Undergoing Treatment With Checkpoint BlockadeMiriam Möller, Steffi Turzer, Wolfgang Schütte, et al.
Pageof 31

Showing results (71-80 of 304) with videos related to

Sort By:
Pageof 31
Cancer Research|December 17, 2008
Altered detoxification status and increased resistance to oxidative stress by K-ras transformationChristian V Recktenwald, Roland Kellner, Rudolf Lichtenfels, et al.
Trends in Molecular Medicine|November 7, 2008
The complex role of B7 molecules in tumor immunologyBarbara Seliger, Francesco M Marincola, Soldano Ferrone, et al.
Journal of Translational Medicine|December 24, 2015
Different maturation cocktails provide dendritic cells with different chemoattractive propertiesChiara Massa, Carolin Thomas, Ena Wang, et al.
Cancers|October 17, 2020
High PD-L1/CD274 Expression of Monocytes and Blood Dendritic Cells Is a Risk Factor in Lung Cancer Patients Undergoing Treatment with PD1 Inhibitor TherapyDagmar Riemann, Wolfgang Schütte, Steffi Turzer, et al.
Trends in Molecular Medicine|March 23, 2010
Antitumour and immune-adjuvant activities of protein-tyrosine kinase inhibitorsBarbara Seliger, Chiara Massa, Brian Rini, et al.
Journal of Translational Medicine|November 24, 2022
Characterization of the effect of histone deacetylation inhibitors on CD8<sup>+</sup> T cells in the context of agingGeorgiana Toma, Eliza Karapetian, Chiara Massa, et al.
International Journal of Cancer|March 3, 2004
Low frequency of HLA haplotype loss associated with loss of heterozygocity in chromosome region 6p21 in clear renal cell carcinomasIsabel Maleno, Miguel Angel Lopez Nevot, Barbara Seliger, et al.
Frontiers in Immunology|April 2, 2021
Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic AvenuesKarthikeyan Subbarayan, Kamatchi Ulagappan, Claudia Wickenhauser, et al.
Cancers|October 14, 2023
Blood Immune Cells as Biomarkers in Long-Term Surviving Patients with Advanced Non-Small-Cell Lung Cancer Undergoing a Combined Immune/ChemotherapyMiriam Möller, Wolfgang Schütte, Steffi Turzer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 9, 2019
Blood Immune Cell Biomarkers in Patient With Lung Cancer Undergoing Treatment With Checkpoint BlockadeMiriam Möller, Steffi Turzer, Wolfgang Schütte, et al.
Pageof 31